Skip to main content

Table 5 Survival (BCSS, OS) for patients with and without ATI in luminal BC and TNBC

From: Active behavior of triple-negative breast cancer with adipose tissue invasion: a single center and retrospective review

  

ATI-negative

ATI-positive

  

Subtype

Survival

No of events/No of patients

No of events/No of patients

Hazard ratio

P Value

  

(%)

(%)

(95%CI)

 

Luminal BC

BCSS

3/54 (6)

47/442 (11)

1.75 (0.55-5.63)

0.346

OS

4/54 (7)a

62/442 (14)a

1.75 (0.64-4.82)

0.277

TNBC

BCSS

1/35 (3)

26/102 (25)

8.63 (1.17-63.66)

0.035

OS

3/35 (9)a

33/102 (32)a

3.63 (1.11-11.84)

0.033

  1. BCSS breast cancer-specific survival, OS overall survival
  2. aData were also shown in Table 4